Retinal nerve fibre layer At baseline and every three months for nine months [clinicaltrials_resource:62d276c14bc8e4ff81db7a14b37ce5df]
The primary aim of this open-label pilot trial is to estimate the treatment effect of 100 mg of oral minocycline twice daily for 90 days, initiated within 30 days of onset of ON, on functional and structural optic nerve recovery compared to no treatment. The primary outcome measure that will be used to measure optic nerve recovery is RNFL thickness.
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Retinal nerve fibre layer At baseline and every three months for nine months [clinicaltrials_resource:62d276c14bc8e4ff81db7a14b37ce5df]
The primary aim of this open-label pilot trial is to estimate the treatment effect of 100 mg of oral minocycline twice daily for 90 days, initiated within 30 days of onset of ON, on functional and structural optic nerve recovery compared to no treatment. The primary outcome measure that will be used to measure optic nerve recovery is RNFL thickness.
Bio2RDF identifier
62d276c14bc8e4ff81db7a14b37ce5df
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:62d276c14bc8e4ff81db7a14b37ce5df
measure [clinicaltrials_vocabulary:measure]
Retinal nerve fibre layer
time frame [clinicaltrials_vocabulary:time-frame]
At baseline and every three months for nine months
description
The primary aim of this open-l ...... ve recovery is RNFL thickness.
identifier
clinicaltrials_resource:62d276c14bc8e4ff81db7a14b37ce5df
title
Retinal nerve fibre layer At baseline and every three months for nine months
@en
type
label
Retinal nerve fibre layer At b ...... 276c14bc8e4ff81db7a14b37ce5df]
@en